Personalized health coaching may improve cognition, lower dementia risk in high-risk older adults
By
Kimberly Bonvissuto
Aug 13, 2024
Personalized dementia risk reduction intervention plans improved cognition and reduced dementia risk among high-risk older adults in a study detailed recently in JAMA Internal Medicine.
Telemedicine increases access to care for assisted living residents with dementia: study
By
Kimberly Bonvissuto
May 30, 2023
Although racial/ethnic and socioeconomically disadvantaged populations were less likely to use telemedicine early in the COVID-19 pandemic, a new study finds that telemedicine offered a way for members...
Investing in people, innovation, efficiencies makes senior living better: panel
By
Kimberly Bonvissuto
Sep 16, 2022
WASHINGTON, DC — A panel of senior living CEOs took the theme of the 2022 National Investment Center for Seniors Housing & Care Fall Conference to heart as they discussed how the industry needs to move...
4 percent of those aged 65+ have dementia diagnoses: report
By
Kimberly Bonvissuto
Jun 14, 2024
Four percent of US adults aged 65 or more years have a dementia diagnosis, with rates of dementia increasing with age, according to newly released data.
‘Significant’ drop in residential care aide workforce during pandemic raises questions about future...
By
Kimberly Bonvissuto
Sep 08, 2022
The residential care aide workforce — personal care aides, home health aides and nursing assistants who work in assisted living communities, continuing care retirement / life plan communities and other...
What one does while sitting could affect dementia risk: study
By
Kimberly Bonvissuto
Aug 24, 2022
What a person does while sitting matters, according to a new study looking at the effects of physical and mental activity on dementia risk.
Recommendations to reduce disparities in dementia care due in 2021
By
Kimberly Bonvissuto
Dec 09, 2020
Final recommendations on ways to reduce disparities in dementia, which were developed during a stakeholder roundtable sponsored by the Milken Institute Alliance to Improve Dementia Care, will be released...
Alzheimer’s experts throw support behind experimental drug despite adverse events, deaths
By
Kimberly Bonvissuto
Dec 01, 2022
Alzheimer’s disease experts are throwing their support behind the drug lecanemab, despite reports of two deaths tied to the experimental monoclonal antibody medication.